What Are Moderna's Risks?
Moderna (NASDAQ: MRNA) is a high-flying biotech stock with a big year ahead of it. The company should make billions of dollars in 2021 from sales of its COVID-19 vaccine mRNA-1273.
In this Motley Fool Live video recorded on Jan. 13, 2021, Healthcare and Cannabis Bureau Chief Corinne Jurney Cardina and Fool.com writer Keith Speights spoke about the risks that remain for Moderna even with the tremendous success of its coronavirus vaccine.
Source Fool.com


